He presented clinical data showing, that RTK-AXL is mainly expressed in pseudo-palisades and GFAP positive tumor cells, whereas the specific ligand of RTK-AXL Gas6 is expressed in hypoxic border zone but not in pseudo-palisades [10]. The gene discussed is AXL; the disease is neoplasm.